Susan Boyle-Vavra - Publications

Affiliations: 
Pediatrics University of Chicago, Chicago, IL 
Area:
Staphylococcus aureus

76 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Greenstein AW, Boyle-Vavra S, Maddox CW, Tang X, Halliday LC, Fortman JD. Carriage of Methicillin-resistant Staphylococcus aureus in a Colony of Rhesus (Macaca mulatta) and Cynomolgus (Macaca fascicularis) Macaques. Comparative Medicine. PMID 31375150 DOI: 10.30802/AALAS-CM-18-000089  0.565
2019 Lee H, Boyle-Vavra S, Ren J, Jarusiewicz J, Sharma LK, Hoagland DT, Yin S, Zhu T, Hevener KE, Ojeda I, Lee RE, Daum RS, Johnson ME. Identification of small molecules exhibiting oxacillin synergy through a novel assay for inhibition of expression in methicillin resistant . Antimicrobial Agents and Chemotherapy. PMID 31209003 DOI: 10.1128/Aac.02593-18  0.629
2019 Luna BM, Nielsen TB, Cheng B, Pantapalangkoor P, Yan J, Boyle-Vavra S, Bruhn KW, Montgomery C, Spellberg B, Daum R. Vaccines targeting Staphylococcus aureus skin and bloodstream infections require different composition. Plos One. 14: e0217439. PMID 31181086 DOI: 10.1371/Journal.Pone.0217439  0.578
2017 Krezalek MA, Hyoju S, Zaborin A, Okafor E, Chandrasekar L, Bindokas V, Guyton K, Montgomery CP, Daum RS, Zaborina O, Boyle-Vavra S, Alverdy JC. Can Methicillin-resistant Staphylococcus aureus Silently Travel From the Gut to the Wound and Cause Postoperative Infection? Modeling the "Trojan Horse Hypothesis". Annals of Surgery. PMID 28187042 DOI: 10.1097/Sla.0000000000002173  0.72
2016 Mir-Sanchis I, Roman CA, Misiura A, Pigli YZ, Boyle-Vavra S, Rice PA. Staphylococcal SCCmec elements encode an active MCM-like helicase and thus may be replicative. Nature Structural & Molecular Biology. PMID 27571176 DOI: 10.1038/Nsmb.3286  0.303
2016 Alegre ML, Chen L, David MZ, Bartman C, Boyle-Vavra S, Kumar N, Chong AS, Daum RS. Impact of Staphylococcus aureus USA300 Colonization and Skin Infections on Systemic Immune Responses in Humans. Journal of Immunology (Baltimore, Md. : 1950). PMID 27402695 DOI: 10.4049/Jimmunol.1600549  0.652
2016 Azarian T, Daum RS, Petty LA, Steinbeck JL, Yin Z, Nolan D, Boyle-Vavra S, Hanage WP, Salemi M, David MZ. Intra-host evolution of methicillin-resistant Staphylococcus aureus USA300 among individuals with reoccurring skin and soft tissue infections. The Journal of Infectious Diseases. PMID 27288537 DOI: 10.1093/Infdis/Jiw242  0.685
2015 Zhao F, Cheng BL, Boyle-Vavra S, Alegre ML, Daum RS, Chong AS, Montgomery CP. Proteomic Identification of saeRS-Dependent Targets Critical for Protective Humoral Immunity against Staphylococcus aureus Skin Infection. Infection and Immunity. 83: 3712-21. PMID 26169277 DOI: 10.1128/Iai.00667-15  0.559
2015 David MZ, Acree ME, Sieth JJ, Boxrud DJ, Dobbins G, Lynfield R, Boyle-Vavra S, Daum RS. Pediatric S. aureus Isolate Genotypes and Infections from the Dawn of the CA-MRSA Epidemic Era in Chicago, 1995-1997. Journal of Clinical Microbiology. PMID 26019202 DOI: 10.1128/Jcm.00096-15  0.722
2015 Gaupp R, Lei S, Reed JM, Peisker H, Boyle-Vavra S, Bayer AS, Bischoff M, Herrmann M, Daum RS, Powers R, Somerville GA. Staphylococcus aureus Metabolic Adaptations during the Transition from a Daptomycin Susceptibility Phenotype to a Daptomycin Nonsusceptibility Phenotype. Antimicrobial Agents and Chemotherapy. 59: 4226-38. PMID 25963986 DOI: 10.1128/Aac.00160-15  0.696
2015 Boyle-Vavra S, Li X, Alam MT, Read TD, Sieth J, Cywes-Bentley C, Dobbins G, David MZ, Kumar N, Eells SJ, Miller LG, Boxrud DJ, Chambers HF, Lynfield R, Lee JC, et al. USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locus. Mbio. 6. PMID 25852165 DOI: 10.1128/Mbio.02585-14  0.657
2015 Alam MT, Read TD, Petit RA, Boyle-Vavra S, Miller LG, Eells SJ, Daum RS, David MZ. Transmission and microevolution of USA300 MRSA in U.S. households: evidence from whole-genome sequencing. Mbio. 6: e00054. PMID 25759497 DOI: 10.1128/Mbio.00054-15  0.669
2015 Kumar N, David MZ, Boyle-Vavra S, Sieth J, Daum RS. High Staphylococcus aureus colonization prevalence among patients with skin and soft tissue infections and controls in an urban emergency department. Journal of Clinical Microbiology. 53: 810-5. PMID 25540401 DOI: 10.1128/Jcm.03221-14  0.681
2015 Miller LG, Eells SJ, David MZ, Ortiz N, Taylor AR, Kumar N, Cruz D, Boyle-Vavra S, Daum RS. Staphylococcus aureus skin infection recurrences among household members: an examination of host, behavioral, and pathogen-level predictors. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 753-63. PMID 25428411 DOI: 10.1093/Cid/Ciu943  0.629
2015 Zhao F, Cheng BL, Boyle-Vavra S, Alegre ML, Daum RS, Chong AS, Montgomery CP. Proteomic identification of saeRS-dependent targets critical for protective humoral immunity against Staphylococcus aureus skin infection Infection and Immunity. 83: 3712-3721. DOI: 10.1128/IAI.00667-15  0.55
2015 Azarian T, Petty L, Yin Z, Boyle-Vavra S, Salemi M, Daum RS, David MZ, Steinbeck JL. Whole-Genome Sequencing (WGS) of 19 Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates From Recurrent Infections in 4 Patients: USA300 Strain Replacement Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.836  0.728
2014 Jones MB, Montgomery CP, Boyle-Vavra S, Shatzkes K, Maybank R, Frank BC, Peterson SN, Daum RS. Genomic and transcriptomic differences in community acquired methicillin resistant Staphylococcus aureus USA300 and USA400 strains. Bmc Genomics. 15: 1145. PMID 25527145 DOI: 10.1186/1471-2164-15-1145  0.757
2014 David MZ, Siegel JD, Henderson J, Leos G, Lo K, Iwuora J, Porsa E, Schumm LP, Boyle-Vavra S, Daum RS. A randomized, controlled trial of chlorhexidine-soaked cloths to reduce methicillin-resistant and methicillin-susceptible Staphylococcus aureus carriage prevalence in an urban jail. Infection Control and Hospital Epidemiology. 35: 1466-73. PMID 25419768 DOI: 10.1086/678606  0.706
2014 Eells SJ, David MZ, Taylor A, Ortiz N, Kumar N, Sieth J, Boyle-Vavra S, Daum RS, Miller LG. Persistent environmental contamination with USA300 methicillin-resistant Staphylococcus aureus and other pathogenic strain types in households with S. aureus skin infections. Infection Control and Hospital Epidemiology. 35: 1373-82. PMID 25333432 DOI: 10.1086/678414  0.733
2014 David MZ, Siegel JD, Henderson J, Leos G, Lo K, Iwuora J, Taylor AR, Zychowski DL, Porsa E, Boyle-Vavra S, Daum RS. Hand and nasal carriage of discordant Staphylococcus aureus isolates among urban jail detainees. Journal of Clinical Microbiology. 52: 3422-5. PMID 24958796 DOI: 10.1128/Jcm.01190-14  0.73
2014 David MZ, Daum RS, Bayer AS, Chambers HF, Fowler VG, Miller LG, Ostrowsky B, Baesa A, Boyle-Vavra S, Eells SJ, Garcia-Houchins S, Gialanella P, Macias-Gil R, Rude TH, Ruffin F, et al. Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 798-807. PMID 24879783 DOI: 10.1093/Cid/Ciu410  0.69
2014 David MZ, Cadilla A, Boyle-Vavra S, Daum RS. Replacement of HA-MRSA by CA-MRSA infections at an academic medical center in the midwestern United States, 2004-5 to 2008. Plos One. 9: e92760. PMID 24755631 DOI: 10.1371/Journal.Pone.0092760  0.641
2014 Qureshi NK, Yin S, Boyle-Vavra S. The role of the Staphylococcal VraTSR regulatory system on vancomycin resistance and vanA operon expression in vancomycin-resistant Staphylococcus aureus. Plos One. 9: e85873. PMID 24454941 DOI: 10.1371/Journal.Pone.0085873  0.592
2014 Miller L, Eells SJ, David MZ, Ortiz N, Boyle-Vavra S, Daum RS. 680Predictors of Recurrent Staphylococcus aureus Skin Infection After Treatment: Host, Behavioral, and Pathogen Level Factors Open Forum Infectious Diseases. 1: S192-S192. DOI: 10.1093/Ofid/Ofu052.388  0.594
2013 David MZ, Siegel J, Lowy FD, Zychowski D, Taylor A, Lee CJ, Boyle-Vavra S, Daum RS. Asymptomatic carriage of sequence type 398, spa type t571 methicillin-susceptible Staphylococcus aureus in an urban jail: a newly emerging, transmissible pathogenic strain. Journal of Clinical Microbiology. 51: 2443-7. PMID 23658269 DOI: 10.1128/Jcm.01057-13  0.708
2013 Misiura A, Pigli YZ, Boyle-Vavra S, Daum RS, Boocock MR, Rice PA. Roles of two large serine recombinases in mobilizing the methicillin-resistance cassette SCCmec. Molecular Microbiology. 88: 1218-29. PMID 23651464 DOI: 10.1111/Mmi.12253  0.577
2013 David MZ, Taylor A, Lynfield R, Boxrud DJ, Short G, Zychowski D, Boyle-Vavra S, Daum RS. Comparing pulsed-field gel electrophoresis with multilocus sequence typing, spa typing, staphylococcal cassette chromosome mec (SCCmec) typing, and PCR for panton-valentine leukocidin, arcA, and opp3 in methicillin-resistant Staphylococcus aureus isolates at a U.S. Medical Center. Journal of Clinical Microbiology. 51: 814-9. PMID 23269731 DOI: 10.1128/Jcm.02429-12  0.707
2013 Boyle-Vavra S, Yin S, Jo DS, Montgomery CP, Daum RS. VraT/YvqF is required for methicillin resistance and activation of the VraSR regulon in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 57: 83-95. PMID 23070169 DOI: 10.1128/Aac.01651-12  0.749
2013 David MZ, Boyle-Vavra S, Zychowski DL, Daum RS. Presence of CDC risk factors for HA-MRSA* among patients with MSSA and MRSA infections. Plos One. DOI: 10.1371/Journal.Pone.0018217.T002  0.631
2012 Ito T, Hiramatsu K, Tomasz A, de Lencastre H, Perreten V, Holden MT, Coleman DC, Goering R, Giffard PM, Skov RL, Zhang K, Westh H, O'Brien F, Tenover FC, Oliveira DC, ... Boyle-Vavra S, et al. Guidelines for reporting novel mecA gene homologues. Antimicrobial Agents and Chemotherapy. 56: 4997-9. PMID 22869575 DOI: 10.1128/Aac.01199-12  0.681
2012 Montgomery CP, Boyle-Vavra S, Roux A, Ebine K, Sonenshein AL, Daum RS. CodY deletion enhances in vivo virulence of community-associated methicillin-resistant Staphylococcus aureus clone USA300. Infection and Immunity. 80: 2382-9. PMID 22526672 DOI: 10.1128/Iai.06172-11  0.661
2012 Miller LG, Eells SJ, Taylor AR, David MZ, Ortiz N, Zychowski D, Kumar N, Cruz D, Boyle-Vavra S, Daum RS. Staphylococcus aureus colonization among household contacts of patients with skin infections: risk factors, strain discordance, and complex ecology. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: 1523-35. PMID 22474221 DOI: 10.1093/Cid/Cis213  0.729
2012 David MZ, Rudolph KM, Hennessy TW, Zychowski DL, Asthi K, Boyle-Vavra S, Daum RS. MRSA USA300 at Alaska Native Medical Center, Anchorage, Alaska, USA, 2000-2006. Emerging Infectious Diseases. 18: 105-8. PMID 22264651 DOI: 10.3201/Eid1801.110746  0.714
2011 David MZ, Boyle-Vavra S, Zychowski DL, Daum RS. Methicillin-susceptible Staphylococcus aureus as a predominantly healthcare-associated pathogen: a possible reversal of roles? Plos One. 6: e18217. PMID 21533238 DOI: 10.1371/Journal.Pone.0018217  0.728
2011 Myers PJ, Marcinak J, David MZ, Zychowski DL, Boyle-Vavra S, Weber S, Daum RS. Universal admission screening for methicillin-resistant Staphylococcus aureus in a level IIID neonatal intensive care unit: the first 9 months. Infection Control and Hospital Epidemiology. 32: 398-400. PMID 21460494 DOI: 10.1086/659153  0.651
2011 Jo DS, Montgomery CP, Yin S, Boyle-Vavra S, Daum RS. Improved oxacillin treatment outcomes in experimental skin and lung infection by a methicillin-resistant Staphylococcus aureus isolate with a vraSR operon deletion. Antimicrobial Agents and Chemotherapy. 55: 2818-23. PMID 21383093 DOI: 10.1128/Aac.01704-10  0.694
2011 Boyle-Vavra S, Jones M, Gourley BL, Holmes M, Ruf R, Balsam AR, Boulware DR, Kline S, Jawahir S, Devries A, Peterson SN, Daum RS. Comparative genome sequencing of an isogenic pair of USA800 clinical methicillin-resistant Staphylococcus aureus isolates obtained before and after daptomycin treatment failure. Antimicrobial Agents and Chemotherapy. 55: 2018-25. PMID 21343446 DOI: 10.1128/Aac.01593-10  0.722
2011 Cadilla A, David MZ, Daum RS, Boyle-Vavra S. Association of high-level mupirocin resistance and multidrug-resistant methicillin-resistant Staphylococcus aureus at an academic center in the midwestern United States. Journal of Clinical Microbiology. 49: 95-100. PMID 21084520 DOI: 10.1128/Jcm.00759-10  0.73
2010 Montgomery CP, Boyle-Vavra S, Daum RS. Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infection. Plos One. 5: e15177. PMID 21151999 DOI: 10.1371/Journal.Pone.0015177  0.635
2010 Boyle-Vavra S, Daum RS. Reliability of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) assay in detecting MRSA isolates with a variety of genotypes from the United States and Taiwan. Journal of Clinical Microbiology. 48: 4546-51. PMID 20881172 DOI: 10.1128/Jcm.02519-09  0.675
2010 Yang SJ, Xiong YQ, Boyle-Vavra S, Daum R, Jones T, Bayer AS. Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect"). Antimicrobial Agents and Chemotherapy. 54: 3161-9. PMID 20547804 DOI: 10.1128/Aac.00487-10  0.687
2009 Crawford SE, David MZ, Glikman D, King KJ, Boyle-Vavra S, Daum RS. Clinical importance of purulence in methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Journal of the American Board of Family Medicine : Jabfm. 22: 647-54. PMID 19897693 DOI: 10.3122/Jabfm.2009.06.090025  0.751
2009 Ito T, Hiramatsu K, Oliveira DC, De Lencastre H, Zhang K, Westh H, O'Brien F, Giffard PM, Coleman D, Tenover FC, Boyle-Vavra S, Skov RL, Enright MC, Kreiswirth B, Kwan SK, et al. Classification of staphylococcal cassette chromosome mec (SCCmec): Guidelines for reporting novel SCCmec elements Antimicrobial Agents and Chemotherapy. 53: 4961-4967. PMID 19721075 DOI: 10.1128/Aac.00579-09  0.479
2009 Montgomery CP, Boyle-Vavra S, Daum RS. The arginine catabolic mobile element is not associated with enhanced virulence in experimental invasive disease caused by the community-associated methicillin-resistant Staphylococcus aureus USA300 genetic background. Infection and Immunity. 77: 2650-6. PMID 19380473 DOI: 10.1128/Iai.00256-09  0.718
2008 David MZ, Rudolph KM, Hennessy TW, Boyle-Vavra S, Daum RS. Molecular epidemiology of methicillin-resistant Staphylococcus aureus, rural southwestern Alaska. Emerging Infectious Diseases. 14: 1693-9. PMID 18976551 DOI: 10.3201/Eid1411.080381  0.759
2008 David MZ, Mennella C, Mansour M, Boyle-Vavra S, Daum RS. Predominance of methicillin-resistant Staphylococcus aureus among pathogens causing skin and soft tissue infections in a large urban jail: risk factors and recurrence rates. Journal of Clinical Microbiology. 46: 3222-7. PMID 18685002 DOI: 10.1128/Jcm.01423-08  0.732
2008 Montgomery CP, Boyle-Vavra S, Adem PV, Lee JC, Husain AN, Clasen J, Daum RS. Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. The Journal of Infectious Diseases. 198: 561-70. PMID 18598194 DOI: 10.1086/590157  0.676
2008 David MZ, Glikman D, Crawford SE, Peng J, King KJ, Hostetler MA, Boyle-Vavra S, Daum RS. What is community-associated methicillin-resistant Staphylococcus aureus? The Journal of Infectious Diseases. 197: 1235-43. PMID 18422435 DOI: 10.1086/533502  0.73
2008 Glikman D, Siegel JD, David MZ, Okoro NM, Boyle-Vavra S, Dowell ML, Daum RS. Complex molecular epidemiology of methicillin-resistant staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S aureus. Chest. 133: 1381-7. PMID 18347206 DOI: 10.1378/Chest.07-2437  0.716
2008 David MZ, Mennella C, Mansour M, Boyle-Vavra S, Daum RS. Predominance of methicillin-resistant Staphylococcus aureus among pathogens causing skin and soft tissue infections in a large urban jail: Risk factors and recurrence rates (Journal of Clinical Microbiology (2008) 46, 10 (3222-3227)) Journal of Clinical Microbiology. 46: 4120. DOI: 10.1128/Jcm.01982-08  0.682
2007 Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerging Infectious Diseases. 13: 236-42. PMID 17479885 DOI: 10.3201/Eid1302.060781  0.73
2007 Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Laboratory Investigation; a Journal of Technical Methods and Pathology. 87: 3-9. PMID 17146447 DOI: 10.1038/Labinvest.3700501  0.703
2006 Boyle-Vavra S, Yin S, Daum RS. The VraS/VraR two-component regulatory system required for oxacillin resistance in community-acquired methicillin-resistant Staphylococcus aureus. Fems Microbiology Letters. 262: 163-71. PMID 16923071 DOI: 10.1111/J.1574-6968.2006.00384.X  0.7
2006 David MZ, Crawford SE, Boyle-Vavra S, Hostetler MA, Kim DC, Daum RS. Contrasting pediatric and adult methicillin-resistant Staphylococcus aureus isolates. Emerging Infectious Diseases. 12: 631-7. PMID 16704812 DOI: 10.3201/Eid1204.050960  0.681
2006 Yin S, Daum RS, Boyle-Vavra S. VraSR two-component regulatory system and its role in induction of pbp2 and vraSR expression by cell wall antimicrobials in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 50: 336-43. PMID 16377706 DOI: 10.1128/Aac.50.1.336-343.2006  0.567
2005 Adem PV, Montgomery CP, Husain AN, Koogler TK, Arangelovich V, Humilier M, Boyle-Vavra S, Daum RS. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. The New England Journal of Medicine. 353: 1245-51. PMID 16177250 DOI: 10.1056/Nejmoa044194  0.72
2005 Boyle-Vavra S, Ereshefsky B, Wang CC, Daum RS. Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel Staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV. Journal of Clinical Microbiology. 43: 4719-30. PMID 16145133 DOI: 10.1128/Jcm.43.9.4719-4730.2005  0.704
2003 Boyle-Vavra S, Challapalli M, Daum RS. Resistance to autolysis in vancomycin-selected Staphylococcus aureus isolates precedes vancomycin-intermediate resistance. Antimicrobial Agents and Chemotherapy. 47: 2036-9. PMID 12760894 DOI: 10.1128/Aac.47.6.2036-2039.2003  0.721
2003 Boyle-Vavra S, Yin S, Challapalli M, Daum RS. Transcriptional induction of the penicillin-binding protein 2 gene in Staphylococcus aureus by cell wall-active antibiotics oxacillin and vancomycin. Antimicrobial Agents and Chemotherapy. 47: 1028-36. PMID 12604538 DOI: 10.1128/Aac.47.3.1028-1036.2003  0.62
2002 Daum RS, Ito T, Hiramatsu K, Hussain F, Mongkolrattanothai K, Jamklang M, Boyle-Vavra S. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. The Journal of Infectious Diseases. 186: 1344-7. PMID 12402206 DOI: 10.1086/344326  0.701
2002 Hussain FM, Boyle-Vavra S, Shete PB, Daum RS. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates. The Journal of Infectious Diseases. 186: 661-7. PMID 12195353 DOI: 10.1086/342708  0.703
2002 Ma XX, Ito T, Tiensasitorn C, Jamklang M, Chongtrakool P, Boyle-Vavra S, Daum RS, Hiramatsu K. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrobial Agents and Chemotherapy. 46: 1147-52. PMID 11897611 DOI: 10.1128/Aac.46.4.1147-1152.2002  0.698
2001 Hussain FM, Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic. The Pediatric Infectious Disease Journal. 20: 763-7. PMID 11734738 DOI: 10.1097/00006454-200108000-00009  0.655
2001 Boyle-Vavra S, Carey RB, Daum RS. Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate. The Journal of Antimicrobial Chemotherapy. 48: 617-25. PMID 11679550 DOI: 10.1093/Jac/48.5.617  0.696
2001 Boyle-Vavra S, Labischinski H, Ebert CC, Ehlert K, Daum RS. A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates. Antimicrobial Agents and Chemotherapy. 45: 280-7. PMID 11120978 DOI: 10.1128/Aac.45.1.280-287.2001  0.678
2000 Hussain FM, Boyle-Vavra S, Bethel CD, Daum RS. Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility. The Pediatric Infectious Disease Journal. 19: 1163-6. PMID 11144377 DOI: 10.1097/00006454-200012000-00009  0.7
2000 Boyle-Vavra S, Hahm J, Sibener SJ, Daum RS. Structural and topological differences between a glycopeptide-intermediate clinical strain and glycopeptide-susceptible strains of Staphylococcus aureus revealed by atomic force microscopy. Antimicrobial Agents and Chemotherapy. 44: 3456-60. PMID 11083659 DOI: 10.1128/Aac.44.12.3456-3460.2000  0.584
2000 Boyle-Vavra S, Berke SK, Lee JC, Daum RS. Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates. Antimicrobial Agents and Chemotherapy. 44: 272-7. PMID 10639349 DOI: 10.1128/Aac.44.2.272-277.2000  0.717
1999 Suggs AH, Maranan MC, Boyle-Vavra S, Daum RS. Methicillin-resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factors. The Pediatric Infectious Disease Journal. 18: 410-4. PMID 10353512 DOI: 10.1097/00006454-199905000-00003  0.696
1998 Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. The Journal of Antimicrobial Chemotherapy. 42: 199-209. PMID 9738837 DOI: 10.1093/Jac/42.2.199  0.685
1998 Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. Jama. 279: 593-8. PMID 9486753 DOI: 10.1001/Jama.279.8.593  0.683
1997 Maranan MC, Moreira B, Boyle-Vavra S, Daum RS. Antimicrobial resistance in staphylococci. Epidemiology, molecular mechanisms, and clinical relevance. Infectious Disease Clinics of North America. 11: 813-49. PMID 9421702 DOI: 10.1016/S0891-5520(05)70392-5  0.729
1997 Boyle-Vavra S, de Jonge BL, Ebert CC, Daum RS. Cloning of the Staphylococcus aureus ddh gene encoding NAD+-dependent D-lactate dehydrogenase and insertional inactivation in a glycopeptide-resistant isolate. Journal of Bacteriology. 179: 6756-63. PMID 9352927 DOI: 10.1128/Jb.179.21.6756-6763.1997  0.647
1997 Moreira B, Boyle-Vavra S, deJonge BL, Daum RS. Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 41: 1788-93. PMID 9257762 DOI: 10.1128/Aac.41.8.1788  0.689
1996 Milewski WM, Boyle-Vavra S, Moreira B, Ebert CC, Daum RS. Overproduction of a 37-kilodalton cytoplasmic protein homologous to NAD+-linked D-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 40: 166-72. PMID 8787900 DOI: 10.1128/Aac.40.1.166  0.618
1996 Boyle-Vavra S, Ebert C, Daum RS. THE VANH-LIKE PROTEIN OF A GLYCOPEPTIDE RESISTANT STRAIN OFSTAPHYLOCOCCUS AUREUS IS NOT NECESSARY FOR THE RESISTANT PHENOTYPE† 989 Pediatric Research. 39: 167-167. DOI: 10.1203/00006450-199604001-01011  0.7
Show low-probability matches.